Conventional antiviral research targets the viruses with drugs called “direct-acting antivirals”. All the current FDA-approved antivirals in clinical use for COVID-19 and influenza are of this kind even when several studies have reported new virus strains that can dodge this medicine. As both SARS-CoV-2 and influenza viruses evolve rapidly to become resistant to direct attacks., Conventional antiviral research targets the viruses with drugs called “direct-acting antivirals”. All the current FDA-approved antivirals in clinical use for COVID-19 and influenza are of this kind even when several studies have reported new virus strains that can dodge this medicine. As both SARS-CoV-2 and influenza viruses evolve rapidly to become resistant to direct attacks., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way